Filing Flows › Cytokinetics (CYTK) › Net Product Revenue revenue
Cytokinetics (CYTK) Net Product Revenue revenue by quarter
Cytokinetics' Net Product Revenue revenue was $44.5M in Q3 2026 (third quarter 2026), +76% from Q2 2026. Over the last 3 quarters it ranged from $4.8M (Q1 2026) to $44.5M (Q3 2026).
| Quarter | Net Product Revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $44.5M | +76% | — |
| Q2 2026 | $25.3M | +429% | — |
| Q1 2026 | $4.8M | — | — |
Q3 2026 at a glance
Cytokinetics, Q3 2026: revenue $47.6M (25× year over year), operating margin -351.3%, net loss $190M, operating cash flow −$124M. The chart follows the revenue to costs, profit and cash.
Questions
What is Cytokinetics' Net Product Revenue revenue?
Cytokinetics' Net Product Revenue revenue was $44.5M in Q3 2026 (third quarter 2026), +76% from Q2 2026.
How has Cytokinetics' Net Product Revenue revenue changed?
Over the last 3 quarters it ranged from $4.8M (Q1 2026) to $44.5M (Q3 2026).